Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma

Scarabelli, C; Gallo, Angelo; Franceschi, Silvia; Campagnutta, E; Piero, Giovanni De; Giorda, Giorgio; Visentin, Maria Caterina; Carbone, Antonino

doi:10.1002/(sici)1097-0142(20000115)88:2<389::aid-cncr21>3.0.co;2-w

Cited by 89 publications

(53 citation statements)

References 34 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] However, as far as we are aware, this is the first publication from a recognised UK Gynaecological Oncology Centre.…”

Section: Discussionmentioning

confidence: 99%

Surgical training in gastrointestinal procedures within a UK gynaecological oncology subspecialty programme

Naik

Galaal

Alagoda

et al. 2009

BJOG

View full text Add to dashboard Cite

Objective An analysis of surgical experience in gastrointestinal procedures within a UK-based gynaecological oncology centre to which subspecialty fellows within the subject are exposed.Design Retrospective study.Setting Northern Gynaecological Oncology Centre, Gateshead, UK.Population All women undergoing bowel surgery over a six-year period, 1 January 2000 to 31 December 2005.Methods Cases were analysed by specialty and grade of surgeon performing the procedure.Main outcome measure Proportion of cases to which subspecialty fellows were exposed.Results Two hundred and sixty-two women (11.5%) underwent bowel surgery out of 2280 women undergoing major surgery for gynaecological cancer. This included ovarian/primary peritoneal cancer in 186 women (71%). Of these 262 cases, 238 operations (91%) were performed by a gynaecological oncologist, 20 (7.5%) were performed jointly with the gastrointestinal surgeons and four (1.5%) were performed solely by the gastrointestinal surgeons. A gynaecological oncology subspecialty fellow performed 21 (8%) and assisted in an additional 204 operations (78%). Perioperative morbidity and mortality statistics in addition to overall survival outcomes were comparable to the published literature.Conclusions A significant proportion of major surgical operations performed within a gynaecological oncology centre require gastrointestinal procedures. The majority of these procedures can be performed by gynaecological oncologists with an acceptable perioperative morbidity and mortality rate. Subspecialty training has the potential to allow trainees significant exposure to these procedures. An accredited post-Fellowship Training Programme can provide the opportunity for hands-on experience to allow gynaecological oncologists the confidence and credibility to perform these procedures independently.

show abstract

“…[3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] However, as far as we are aware, this is the first publication from a recognised UK Gynaecological Oncology Centre.…”

Section: Discussionmentioning

confidence: 99%

Surgical training in gastrointestinal procedures within a UK gynaecological oncology subspecialty programme

Naik

Galaal

Alagoda

et al. 2009

BJOG

View full text Add to dashboard Cite

show abstract

“…In the case of patients with advanced OC (FIGO stage III/IV), who are treated with systemic, platinum-based chemotherapy, the completeness of the surgery is one of the most relevant positive prognosis factors (74,(112)(113)(114)(115)(116)(117). (Level I evidence).…”

Section: Topic 7: Is It Right From An Ethical Point Of View To Subjecmentioning

confidence: 99%

1^stEvidence-based Italian Consensus Conference on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Ovarian Cancer

Cavaliere

Cirocchi

Catena

et al. 2017

Tumori

View full text Add to dashboard Cite

Ovarian cancer (OC) remains relatively rare, although it is among the top 4 causes of cancer death for women younger than 50. The aggressive nature of the disease and its often late diagnosis with peritoneal involvement have an impact on prognosis. The current scientific literature presents ambiguous or uncertain indications for management of peritoneal carcinosis (PC) from OC, both owing to the lack of sufficient scientific data and their heterogeneity or lack of consistency. Therefore, the Italian Society of Surgical Oncology (SICO), the Italian Society of Obstetrics and Gynaecology, the Italian Association of Hospital Obstetricians and Gynaecologists, and the Italian Association of Medical Oncology conducted a multidisciplinary consensus conference (CC) on management of advanced OC presenting with PC during the SICO annual meeting in Naples, Italy, on September 10-11, 2015. An expert committee developed questions on diagnosis and staging work-up, indications, and procedural aspects for peritonectomy, systemic chemotherapy, and hyperthermic intraperitoneal chemotherapy for PC from OC. These questions were provided to 6 invited speakers who answered with an evidence-based report. Each report was submitted to a jury panel, representative of Italian experts in the fields of surgical oncology, gynecology, and medical oncology. The jury panel revised the reports before and after the open discussion during the CC. This article is the final document containing the clinical evidence reports and statements, revised and approved by all the authors before submission.

show abstract

“…Einsenkop in 1991 published the block resection of rectosigmoid with uterus, pelvic peritoneum or not, over the elevator muscles of anus promoting the modified posterior exenteration denomination. Subsequently published several experiences reflecting the frequency, safety, efficacy and the low rate of complications of the procedure [21][22][23][24][25][26][27][28][29] . Revaux in 2012 compared morbidity and survival of the modified posterior exenteration during primary surgery or interval, showing a survival improvement when MPE was performed during the first surgery (49.4 vs 27.1 months) with no differences in digestive complications or no digestive [30] .…”

Section: Discussionmentioning

confidence: 99%

Modified Posterior Exenteration in Ovarian Cancer, Frequency and Morbidity of the Procedure

Illia¹,

Internationals²

2018

JGNB

View full text Add to dashboard Cite

Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma

Cited by 89 publications

References 34 publications

Surgical training in gastrointestinal procedures within a UK gynaecological oncology subspecialty programme

Surgical training in gastrointestinal procedures within a UK gynaecological oncology subspecialty programme

1^stEvidence-based Italian Consensus Conference on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Ovarian Cancer

Modified Posterior Exenteration in Ovarian Cancer, Frequency and Morbidity of the Procedure

Contact Info

Product

Resources

About

Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma

Cited by 89 publications

References 34 publications

Surgical training in gastrointestinal procedures within a UK gynaecological oncology subspecialty programme

Surgical training in gastrointestinal procedures within a UK gynaecological oncology subspecialty programme

1stEvidence-based Italian Consensus Conference on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Ovarian Cancer

Modified Posterior Exenteration in Ovarian Cancer, Frequency and Morbidity of the Procedure

Contact Info

Product

Resources

About

1^stEvidence-based Italian Consensus Conference on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Ovarian Cancer